103 related articles for article (PubMed ID: 16288335)
1. [Experimental study of interstitial chemotherapy with PYM delivered from a solid implantable biodegradable polymer against human tongue SCC in tumor-bearing nude mice].
Chen CJ; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):519-24. PubMed ID: 16288335
[TBL] [Abstract][Full Text] [Related]
2. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice.
Gong JH; Liu XJ; Li Y; Zhen YS
Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells.
Ho YC; Tai KW; Chang YC
Oral Dis; 2007 Jan; 13(1):40-4. PubMed ID: 17241428
[TBL] [Abstract][Full Text] [Related]
4. [Use of monoclonal antibody-pinyangmycin conjugate in experimental regional targeting therapy of tumor].
Wang WG; Xu LN; Zhang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1997 Sep; 32(9):669-74. PubMed ID: 11596291
[TBL] [Abstract][Full Text] [Related]
5. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells.
Zheng G; Zhou M; Ou X; Peng B; Yu Y; Kong F; Ouyang Y; He Z
FEBS J; 2010 Nov; 277(21):4506-18. PubMed ID: 21040473
[TBL] [Abstract][Full Text] [Related]
6. [Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro].
Sun ML; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Jun; 28(3):257-60. PubMed ID: 20635652
[TBL] [Abstract][Full Text] [Related]
7. [The effect of ginkgolic acids on multidrug resistance in oral squamous cell carcinoma].
Wang H; Zhou CC; Feng Y; Dai LN; Chen J; Chen SX; Li XY; Liu YR; Zhang P
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Dec; 28(6):668-71. PubMed ID: 21365850
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
Dai Y; Liu XJ; Zhen YS
Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the conjugate composed of a human monoclonal antibody and pingyangmycin on mammary cancer].
Wang WG; Wang SH; Xue YC; Zhen YS
Yao Xue Xue Bao; 1995; 30(8):583-7. PubMed ID: 8571778
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in KB cells by pingyangmycin.
Tai KW; Chou MY; Hu CC; Yang JJ; Chang YC
Oral Oncol; 2000 Mar; 36(2):242-7. PubMed ID: 10745179
[TBL] [Abstract][Full Text] [Related]
11. [Combined injection of pingyangmycin & dexamethasone for the treatment of maxillofacial and cervical venous malformations].
Zhai J; Zhai XD
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):168-71. PubMed ID: 22870701
[TBL] [Abstract][Full Text] [Related]
12. Neochlorogenic acid enhances the antitumor effects of pingyangmycin via regulating TOP2A.
Che J; Zhao T; Liu W; Chen S; Yang G; Li X; Liu D
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355372
[TBL] [Abstract][Full Text] [Related]
13. [Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph node metastasis].
Sun ML; Xie WH; Wang CM; Wen YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Jun; 29(3):253-6, 263. PubMed ID: 21776848
[TBL] [Abstract][Full Text] [Related]
14. [Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Sun ML; Wen YM; Wang CM; Li LJ; Wang XY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):183-5. PubMed ID: 15293458
[TBL] [Abstract][Full Text] [Related]
15. Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations.
Chen F; Song S; Wang H; Zhang W; Lin C; Ma S; Ye T; Zhang L; Yang X; Qin X; Pan W
Int J Pharm; 2014 Dec; 476(1-2):232-40. PubMed ID: 25283699
[TBL] [Abstract][Full Text] [Related]
16. Phosphoinositide 3-kinase/Akt pathway is involved in pingyangmycin‑induced growth inhibition, apoptosis and reduction of invasive potential in EOMA mouse hemangioendothelioma cells.
Peng LX; Zhao P; Zhao HS; Pan E; Yang BB; Li Q
Mol Med Rep; 2015 Dec; 12(6):8275-81. PubMed ID: 26498320
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-based liposomal thermogels for the controlled delivery of pingyangmycin: design, optimization and in vitro and in vivo studies.
Zhang L; Chen F; Zheng J; Wang H; Qin X; Pan W
Drug Deliv; 2018 Nov; 25(1):690-702. PubMed ID: 29484910
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
Liu X; Shang B; Liu X
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):201-4. PubMed ID: 11798873
[TBL] [Abstract][Full Text] [Related]
19. [Expression of X-linked inhibitor of apoptosis protein in Tca8113 cell and its relationship to chemoresistance].
Wang JF; Zhang ZM; Wang CK; Nie DB; Gao WX
Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Feb; 28(1):92-4. PubMed ID: 20337086
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Treatment of Large Venous Malformations in the Oral and Maxillofacial Regions Using Electrochemical Therapy Combined With Pingyangmycin.
Xue L; Cao RY; Xu DP; Sun NN; Tan HS; Wang XK
J Oral Maxillofac Surg; 2015 Jul; 73(7):1384-91. PubMed ID: 25913514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
